Status:
COMPLETED
Piloting a Smartphone App to Improve Treatment Adherence Among South African Adolescents Living With HIV
Lead Sponsor:
Duke University
Collaborating Sponsors:
University of Cape Town
University of North Carolina
Conditions:
HIV Infections
Adolescent Behavior
Eligibility:
All Genders
15-21 years
Phase:
NA
Brief Summary
The overall goal of this pilot randomized-controlled trial (RCT) is to pilot MASI (MAsakhane Siphucule Impilo Yethu; Xhosa for "Let's empower each other and improve our health"), an ART adherence-supp...
Detailed Description
Interventions that engage adolescents and young adults with HIV (AYAHIV) to improve adherence to antiretroviral therapy (ART) are urgently needed. AYAHIV repeatedly demonstrate suboptimal adherence to...
Eligibility Criteria
Inclusion
- Age \>= 15 years and \<= 21 years
- Knows HIV status (Screened adolescents who do not know their HIV status will receive information on free voluntary HIV counseling and testing services)
- Living with HIV
- Has been prescribed medication to treat HIV
- Not attending school for learners with special needs (e.g., School of Skills)
- Has not repeated a grade in school more than once
- Has a smartphone that can download apps
- Feels comfortable using an app with content in English
- No plan to move outside of Cape Town in the next six months
- Has not previously participated in the MASI app testing phase of our study
- Able to successfully install the MASI app on their smartphone
Exclusion
- Failure to meet any of the inclusion criteria
- Child dissent despite parent, legal guardian, caregiver informed consent
Key Trial Info
Start Date :
June 21 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 2 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04661878
Start Date
June 21 2022
End Date
April 2 2024
Last Update
June 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Cape Town
Cape Town, South Africa